Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate LivaNova PLC before investing.

In this article, we go over a few key elements for understanding LivaNova PLC’s stock price such as:

• LivaNova PLC’s current stock price and volume
• Why LivaNova PLC’s stock price changed recently
• Upgrades and downgrades for LIVN from analysts
• LIVN’s stock price momentum as measured by its relative strength

About LivaNova PLC (LIVN)

Before we jump into LivaNova PLC’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.

Want to learn more about LivaNova PLC’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about LivaNova PLC.

LivaNova PLC’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, LivaNova PLC’s stock price was $80.140.

LivaNova PLC is down 1.12% from its previous closing price of $81.050.

During the last market session, LivaNova PLC’s stock traded between $79.295 and $81.780. Currently, there are approximately 54.69 million shares outstanding for LivaNova PLC.

LivaNova PLC’s price-earnings (P/E) ratio is currently at 41.2, which is high compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

LivaNova PLC Stock Price History

LivaNova PLC’s (LIVN) price is currently down 2.54% so far this month.

During the month of July, LivaNova PLC’s stock price has reached a high of $85.270 and a low of $75.300.

Over the last year, LivaNova PLC has hit prices as high as $85.270 and as low as $41.015. Year to date, LivaNova PLC’s stock is up 30.25%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused LivaNova PLC Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded LivaNova PLC’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate LivaNova PLC’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on LivaNova PLC’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

LivaNova PLC’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about LivaNova PLC (LIVN) by visiting AAII Stock Evaluator.

Relative Price Strength of LivaNova PLC

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, LivaNova PLC has a weighted four-quarter relative price strength of 16.26%, which translates to a Momentum Score of 90 and is considered to be Very Strong.

Want to learn more about how LivaNova PLC is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

LivaNova PLC Stock Price: Bottom Line

As of July 31, 2026, LivaNova PLC’s stock price is $80.140, which is down 1.12% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like LivaNova PLC stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.